Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Biosecure Act
BIOSECURE Act set for Congress vote after inclusion in annual defence bill
Lunai Bioworks Advances
Lunai Bioworks Advances Parkinson’s Subtype Targets Toward Preclinical Validation
Akari Therapeutics Highlights
Akari Therapeutics Highlights Preclinical Data Demonstrating Therapeutic Potential of Lead Candidate, AKTX-101, for Hard-to-Treat K-Ras Mutant Pancreatic Cancer
UK and US agree on landmark pharma pricing tariff deal
The UK and US have agreed to keep tariffs on UK pharmaceutical shipments into the US at zero.
Parkinson's drug as basis for new anti-infectives
Pseudomonas aeruginosa – one of the most common hospital germs – has sophisticated mechanisms to efficiently infect the human body and evade the immune system or antibiotics.
Modified herpes virus helps destroy glioblastoma in preclinical models
Researchers at Mass General Brigham have modified a herpes simplex virus (HSV-1) that stimulates the immune system to attack glioblastoma cells.
Curi Bio: $10 Million Series B Closed To Scale Human-Relevant Preclinical Platforms
Curi Bio has secured a $10 million Series B round led by Seoul-based contract research organization DreamCIS, funding that will accelerate the expansion of the company’s integrated human-relevant pr...
Bayer takes Alport syndrome drug into phase 2
Bayer has started a phase 2a trial of an antibody that it hopes could provide a targeted, potentially disease-modifying therapy for Alport syndrome, a rare, genetic disease that leads to chronic kidne...
FDA Grants Priority Review to Sonrotoclax
FDA Grants Priority Review to Sonrotoclax for R/R Mantle Cell Lymphoma
Valneva trims R&D footprint by shutting French facility
The consolidation comes a week after the vaccine specialist downgraded its 2025 guidance.
Glenmark Pharmaceuticals Receives US
Glenmark Pharmaceuticals Receives US FDA Compliance Report for Monroe Manufacturing Facility
Where tomorrow’s medicines begin and Africa’s health future is forged
South Africa’s pharmaceutical landscape is marked by ambition, urgency and stark inequities.
13
14
15
16
17
18
19
20
21
